Rialto Wealth Management LLC Takes $215,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Rialto Wealth Management LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 2,336 shares of the medical device company’s stock, valued at approximately $215,000.

Several other institutional investors have also recently added to or reduced their stakes in COO. State Street Corp grew its stake in shares of Cooper Companies by 1.2% during the third quarter. State Street Corp now owns 8,590,689 shares of the medical device company’s stock valued at $947,897,000 after purchasing an additional 104,521 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after acquiring an additional 573,908 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Cooper Companies by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company’s stock valued at $527,476,000 after purchasing an additional 48,559 shares during the period. Victory Capital Management Inc. boosted its holdings in shares of Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock valued at $415,985,000 after buying an additional 574,899 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company’s stock worth $200,665,000 after purchasing an additional 194,118 shares during the period. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Performance

Shares of NASDAQ COO opened at $85.00 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $16.96 billion, a price-to-earnings ratio of 43.59, a P/E/G ratio of 2.25 and a beta of 1.02. The stock’s fifty day moving average price is $92.38 and its two-hundred day moving average price is $99.40. The Cooper Companies, Inc. has a one year low of $82.61 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Friday. Piper Sandler reiterated an “overweight” rating and set a $115.00 price target (down previously from $120.00) on shares of Cooper Companies in a report on Friday. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Citigroup decreased their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday. Finally, Stifel Nicolaus cut their price target on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a report on Friday. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $111.89.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.